These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4672397)

  • 21. [Cytodiagnosis of non-papillary carcinoma of the bladder and its clinico-pathological significance].
    Yamada T; Shibasaki M; Takagi M; Yokogawa M; Inada T; Fukui I
    Rinsho Byori; 1980; Suppl():188-99. PubMed ID: 7411958
    [No Abstract]   [Full Text] [Related]  

  • 22. [Standards and perspectives in diagnosis and therapy of bladder carcinoma].
    Stief C; Zaak D; Stöckle M; Studer U; Knuechel R; Rödel C; Sauer R; Rubben H
    Urologe A; 2006 Sep; 45 Suppl 4():90-6. PubMed ID: 16896761
    [No Abstract]   [Full Text] [Related]  

  • 23. [Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].
    Denzinger S; Hartmann A; Hofstaedter F; Knuechel R; Wild PJ; Zaak D; Stief C; Wieland WF; Stoehr R; Burger M
    Urologe A; 2007 Sep; 46(9):1126-8. PubMed ID: 17634910
    [No Abstract]   [Full Text] [Related]  

  • 24. [Contribution of bladder biopsy to the study of urogynaecological patient].
    Flores-Carreras O; Martínez-Espinoza CJ; González-Ruiz MI; Montes-Casillas YE
    Ginecol Obstet Mex; 2010 Mar; 78(3):187-90. PubMed ID: 20939223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of cytologic diagnosis in bladder neoplasms.
    Kapila K; Wadhwa SN; Verma K
    Indian J Med Res; 1984 Sep; 80():314-20. PubMed ID: 6526439
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnosis of clinically occult bladder cancer by in vivo staining with methylene blue.
    Mufti GR; Shah PJ; Parkinson MC; Riddle PR
    Br J Urol; 1990 Feb; 65(2):173-5. PubMed ID: 1690584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transitional cell carcinoma of the bladder in a young adult.
    Khan SA; Srinivas V
    Urol Int; 1985; 40(4):238-9. PubMed ID: 4049583
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bladder lymphoma associated with papillary carcinoma].
    Sánchez García A; Amián Martínez A; Cano Martínez R
    Arch Esp Urol; 1988 May; 41(4):317-8. PubMed ID: 3052317
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?
    Bolenz C; West AM; Ortiz N; Kabbani W; Lotan Y
    Urol Oncol; 2013 Apr; 31(3):366-71. PubMed ID: 21414815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-invasive urinary diagnosis of bladder cancer. What do we know?].
    Kausch I; Böhle A
    Urologe A; 2003 Jul; 42(7):912-21. PubMed ID: 12898034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fluorescence in situ hybridization in diagnosis of urinary bladder cancer].
    Stroganova AM; Khachaturian AV
    Arkh Patol; 2006; 68(5):43-6. PubMed ID: 17144532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cytologic diagnosis of transitional cell tumors of the urinary bladder and its histologic basis. A study of 567 cases of urinary-tract disorder including 170 untreated and 182 irradiated bladder tumors.
    Esposti PL; Moberger G; Zajicek J
    Acta Cytol; 1970 Mar; 14(3):145-55. PubMed ID: 4985639
    [No Abstract]   [Full Text] [Related]  

  • 33. Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor.
    Casella R; Huber P; Blöchlinger A; Stoffel F; Dalquen P; Gasser TC; Lehmann K
    J Urol; 2000 Dec; 164(6):1926-8. PubMed ID: 11061883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Case reports on 2 young sisters with superficial bladder neoplasm].
    Tucci G; Pacella A
    G Chir; 1988 Jan; 9(1):36-9. PubMed ID: 3153958
    [No Abstract]   [Full Text] [Related]  

  • 35. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
    Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
    Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic value of urinary cytology in patients with bladder carcinoma.
    Schoonees R; Gamarra MG; Moore RH; Murphy GP
    J Urol; 1971 Nov; 106(5):693-6. PubMed ID: 5115726
    [No Abstract]   [Full Text] [Related]  

  • 37. Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes.
    Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K
    Anal Quant Cytol Histol; 1994 Feb; 16(1):1-10. PubMed ID: 8011035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotic syndrome associated with transitional cell carcinoma of urinary bladder.
    Reshi AR; Mir SA; Gangoo AA; Shah S; Banday K
    Scand J Urol Nephrol; 1997 Jun; 31(3):295-6. PubMed ID: 9249896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is cystoscopy indicated for incidentally identified bladder wall thickening?
    McPartlin DS; Klausner AP; Nottingham CU; Wolters JP; Petrossian A; Carucci LR; Grob BM
    Can J Urol; 2013 Feb; 20(1):6615-9. PubMed ID: 23433131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.